COMBINATION OF EEF2K INHIBITION AND CISPLATIN AS A PROMISING COMBINED THERAPEUTIC APPROACH FOR HIGH-RISK MEDULLOBLASTOMA PATIENTS

PEDIATRIC BLOOD & CANCER(2022)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要